Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Simona Moscatiello, Raffaella Di Luzio & Giulio Marchesini. (2012) Author's reply: Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome. Expert Opinion on Pharmacotherapy 13:2, pages 289-290.
Read now
Read now
Niki Katsiki, Vasilios G Athyros, Asterios Karagiannis & Dimitri P Mikhailidis. (2012) Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome. Expert Opinion on Pharmacotherapy 13:2, pages 287-288.
Read now
Read now
Articles from other publishers (12)
I. Yu. Pirogova, S. P. Sinitsyn & V. S. Chulkov. (2020) Clinical efficacy of Heptrong in patients with non-alcoholic liver disease in real clinical practice (pilot study). Experimental and Clinical Gastroenterology:12, pages 109-118.
Crossref
Crossref
Nian Tan, Xinle Li, Lidong Zhai, Daquan Liu, Jie Li, Hiroki Yokota & Ping Zhang. (2018) Effects of knee loading on obesity-related non-alcoholic fatty liver disease in an ovariectomized mouse model with high-fat diet. Hepatology Research 48:10, pages 839-849.
Crossref
Crossref
Yayoi Kawata, Shoki Okuda, Natsu Hotta, Hideyuki Igawa, Masashi Takahashi, Minoru Ikoma, Shizuo Kasai, Ayumi Ando, Yoshinori Satomi, Mayumi Nishida, Masaharu Nakayama, Syunsuke Yamamoto, Yasutaka Nagisa & Shiro Takekawa. (2017) A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models. European Journal of Pharmacology 796, pages 45-53.
Crossref
Crossref
Monique C. de Oliveira, Eduardo H. Gilglioni, Bouke A. de Boer, Jurgen H. Runge, Dirk R. de Waart, Clairce L. Salgueiro, Emy L. Ishii-Iwamoto, Ronald P.J. Oude Elferink & Ingrid C. Gaemers. (2016) Bile acid receptor agonists INT747 and INT777 decrease oestrogen deficiency-related postmenopausal obesity and hepatic steatosis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:11, pages 2054-2062.
Crossref
Crossref
Hiroya Yamada, Koji Ohashi, Koji Suzuki, Eiji Munetsuna, Yoshitaka Ando, Mirai Yamazaki, Hiroaki Ishikawa, Naohiro Ichino, Ryouji Teradaira & Shuji Hashimoto. (2015) Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease. Clinica Chimica Acta 446, pages 267-271.
Crossref
Crossref
Felice Mangeri, Luca Montesi, Gabriele Forlani, Riccardo Dalle Grave & Giulio Marchesini. (2014) A standard ballroom and Latin dance program to improve fitness and adherence to physical activity in individuals with type 2 diabetes and in obesity. Diabetology & Metabolic Syndrome 6:1.
Crossref
Crossref
Gianluca Iacobellis, Giorgio Barbarini, Claudio Letizia & Giuseppe Barbaro. (2014) Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity 22:2, pages 332-336.
Crossref
Crossref
Hiroya Yamada, Koji Suzuki, Naohiro Ichino, Yoshitaka Ando, Akira Sawada, Keisuke Osakabe, Keiko Sugimoto, Koji Ohashi, Ryouji Teradaira, Takashi Inoue, Nobuyuki Hamajima & Shuji Hashimoto. (2013) Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clinica Chimica Acta 424, pages 99-103.
Crossref
Crossref
Hemant Poudyal, Senthil A. Kumar, Aarjit Iyer, Jennifer Waanders, Leigh C. Ward & Lindsay Brown. (2013) Responses to oleic, linoleic and α-linolenic acids in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. The Journal of Nutritional Biochemistry 24:7, pages 1381-1392.
Crossref
Crossref
Takumi Hirata, Kengo Tomita, Toshihide Kawai, Hirokazu Yokoyama, Akira Shimada, Masahiro Kikuchi, Hiroshi Hirose, Hirotoshi Ebinuma, Junichiro Irie, Keisuke Ojiro, Yoichi Oikawa, Hidetsugu Saito, Hiroshi Itoh & Toshifumi Hibi. (2013) Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY). International Journal of Endocrinology 2013, pages 1-9.
Crossref
Crossref
Yi Tan, Weiguo Lao, Linda Xiao, Zhenzhong Wang, Wei Xiao, Mohamed A. Kamal, J. Paul Seale & Xianqin Qu. (2013) Managing the Combination of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome with Chinese Herbal Extracts in High-Fat-Diet Fed Rats. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-10.
Crossref
Crossref
V. Nobili, G. Bedogni, R. Berni Canani, P. Brambilla, S. Cianfarani, A. Pietrobelli & C. Agostoni. (2012) The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk?. Pediatric Obesity 7:6.
Crossref
Crossref